Search research articles
Contact Us
Filters
Showing results (1-10 of 124) with videos related to
Page
of 13
Sort By:
Breast Cancer Research : BCR
|
June 27, 2022
Know thy cells: commonly used triple-negative human breast cancer cell lines carry mutations in RAS and effectors
Kay-Uwe Wagner
Breast Cancer Research : BCR
|
December 19, 2003
Models of breast cancer: quo vadis, animal modeling?
Kay-Uwe Wagner
Journal of Mammary Gland Biology and Neoplasia
|
January 30, 2008
Jak2/Stat5 signaling in mammogenesis, breast cancer initiation and progression
Kay-Uwe Wagner, Hallgeir Rui
Journal of Life Sciences (Westlake Village, Calif.)
|
February 26, 2020
Regulation and New Treatment Strategies in Breast Cancer
Rosa-Maria Ferraiuolo, Kay-Uwe Wagner
Journal of Carcinogenesis
|
January 27, 2012
The two faces of Janus kinases and their respective STATs in mammary gland development and cancer
Kay-Uwe Wagner, Jeffrey W Schmidt
Cancers
|
December 9, 2023
Cellular Plasticity in Mammary Gland Development and Breast Cancer
Madison N Wicker, Kay-Uwe Wagner
Journal of Mammary Gland Biology and Neoplasia
|
May 12, 2005
Pregnancy and stem cell behavior
Kay-Uwe Wagner, Gilbert H Smith
Cancer Metastasis Reviews
|
September 7, 2021
Models of pancreatic ductal adenocarcinoma
Rayane Dennaoui, Hridaya Shrestha, Kay-Uwe Wagner
Molecular and Cellular Endocrinology
|
April 9, 2013
D-type Cyclins are important downstream effectors of cytokine signaling that regulate the proliferation of normal and neoplastic mammary epithelial cells
Qian Zhang, Kazuhito Sakamoto, Kay-Uwe Wagner
Cancer Research
|
March 28, 2014
Cancer cell dormancy in novel mouse models for reversible pancreatic cancer: a lingering challenge in the development of targeted therapies
Wan-Chi Lin, Nirakar Rajbhandari, Kay-Uwe Wagner
Page
of 13
Search research articles
Search
Showing results (1-10 of 124) with videos related to
Sort By:
Page
of 13
Breast Cancer Research : BCR
|
June 27, 2022
Know thy cells: commonly used triple-negative human breast cancer cell lines carry mutations in RAS and effectors
Kay-Uwe Wagner
Breast Cancer Research : BCR
|
December 19, 2003
Models of breast cancer: quo vadis, animal modeling?
Kay-Uwe Wagner
Journal of Mammary Gland Biology and Neoplasia
|
January 30, 2008
Jak2/Stat5 signaling in mammogenesis, breast cancer initiation and progression
Kay-Uwe Wagner, Hallgeir Rui
Journal of Life Sciences (Westlake Village, Calif.)
|
February 26, 2020
Regulation and New Treatment Strategies in Breast Cancer
Rosa-Maria Ferraiuolo, Kay-Uwe Wagner
Journal of Carcinogenesis
|
January 27, 2012
The two faces of Janus kinases and their respective STATs in mammary gland development and cancer
Kay-Uwe Wagner, Jeffrey W Schmidt
Cancers
|
December 9, 2023
Cellular Plasticity in Mammary Gland Development and Breast Cancer
Madison N Wicker, Kay-Uwe Wagner
Journal of Mammary Gland Biology and Neoplasia
|
May 12, 2005
Pregnancy and stem cell behavior
Kay-Uwe Wagner, Gilbert H Smith
Cancer Metastasis Reviews
|
September 7, 2021
Models of pancreatic ductal adenocarcinoma
Rayane Dennaoui, Hridaya Shrestha, Kay-Uwe Wagner
Molecular and Cellular Endocrinology
|
April 9, 2013
D-type Cyclins are important downstream effectors of cytokine signaling that regulate the proliferation of normal and neoplastic mammary epithelial cells
Qian Zhang, Kazuhito Sakamoto, Kay-Uwe Wagner
Cancer Research
|
March 28, 2014
Cancer cell dormancy in novel mouse models for reversible pancreatic cancer: a lingering challenge in the development of targeted therapies
Wan-Chi Lin, Nirakar Rajbhandari, Kay-Uwe Wagner
Page
of 13